Tomer Pelleg

Tomer Pelleg practices at Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System.

Tomer Pelleg's NPI, 1003158700, was assigned on March 20, 2013. Tomer Pelleg graduated from Philadelphia College of Osteopathic Medicine in 2013. Tomer Pelleg holds Oregon license DO191573.

Tomer Pelleg's primary practice is Good Samaritan Regional Medical Center, at 3600 NW Samaritan Drive, Corvallis, OR 97339 in Benton County. The practice phone is (541) 768-5111.

Tomer Pelleg's primary practice is Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System. Tomer Pelleg is also affiliated with Samaritan Albany General Hospital. The medical group on file is Good Samaritan Regional Medical Center. Dmand AI also links Tomer Pelleg to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tomer Pelleg practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Tomer Pelleg's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Tomer Pelleg is board certified in critical care medicine by the American Board of Internal Medicine. Tomer Pelleg is licensed in Oregon.

CMS data shows 1,000 Medicare services from Tomer Pelleg across 10 procedure codes in 2024, for 397 Medicare patients. Medicare paid $39,410 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 397 Medicare patients who saw Tomer Pelleg in 2024. The largest group is 65 to 74, with 180 patients. 73% of them have high blood pressure, and 63% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tomer Pelleg's median patient age at 68, with 56% women.

In 2024, Tomer Pelleg wrote 680 Medicare Part D claims for 126 patients. 45% of them were for generic drugs. CMS names the drug for 482 of them, across 18 drugs with 11 or more claims each, at $621,269 in total drug cost. In 2023, CMS named 167 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Tomer Pelleg for performance year 2024, reported as part of a group. Tomer Pelleg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tomer Pelleg as offering telehealth.

Dmand AI links 4 papers to Tomer Pelleg, published from 2017 to 2021. 2021 was the busiest year, with 3. Tomer Pelleg's most frequent co-authors are Susanti Rahaju Ie, MD, Anthony Lukas Loschner, MD and Frank Hugo Biscardi, MD.

CMS Open Payments shows 67 general payments to Tomer Pelleg from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Genentech, Inc. paid the most, $432.

Tomer Pelleg graduated from Philadelphia College of Osteopathic Medicine in 2013.